Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MYGN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MYGN investment potential.

What is MYGN stock price today?

Get real-time MYGN stock price, historical data, and price charts on Financhill. Track MYGN performance with our advanced analysis tools.

Is MYGN a good investment?

Evaluate MYGN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MYGN stock?

To buy MYGN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MYGN?

View detailed market capitalization data and company valuation metrics for MYGN on our comprehensive analysis page.

What is the P/E ratio of MYGN?

Use our fundamental analysis tools to view MYGN P/E ratio and compare valuation metrics with industry peers.

What are MYGN earnings?

View MYGN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Myriad Genetics, Inc. 10K Form

Sell

MYGN
Myriad Genetics, Inc.

Last Price:

$7.34

Seasonality Move:

17.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08	10Q	MYGN/Myriad Genetics, Inc. Quarterly
2023-11-07	10Q	MYGN/Myriad Genetics, Inc. Quarterly
2023-08-04	10Q	MYGN/Myriad Genetics, Inc. Quarterly
2023-05-04	10Q	MYGN/Myriad Genetics, Inc. Quarterly
2022-11-02	10Q	MYGN/Myriad Genetics, Inc. Quarterly
2022-08-05	10Q	MYGN/Myriad Genetics, Inc. Quarterly

Receive MYGN News And Ratings

See the #1 stock for the next 7 days that we like better than MYGN

MYGN Financial Statistics

Sales & Book Value

Annual Sales:	$837.6M
Cash Flow:	$14.9M
Price / Cash Flow:	0
Annual Sales:	$4.00
Price / Book:	1.83

Profitability

EPS (TTM):	-4.33490
Net Income (TTM):	$-400.5M
Gross Margin:	$585.4M
Return on Equity:	-69.09%
Return on Assets:	-44.3%

Myriad Genetics, Inc. Earnings Forecast

Key Myriad Genetics, Inc. Financial Ratios

The Gross Profit Margin over the past 30 years for MYGN is 69.89%.
The Selling, General & Administrative Expenses for MYGN have been equal to 66.86% of Gross Profit Margin.
The Research & Development expenses have been 13.54% of Revenue.
The Net Earning history of MYGN is -15.20% of Total Revenues.
Per Share Earnings over the last 30 years have been positive in 14 years.

Myriad Genetics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	MYGN
CUSIP:	62855J
Website:	myriad.com

Debt

Debt-to-Equity Ratio:	0.57
Current Ratio:	2.33
Quick Ratio:	1.78

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	109.31

MYGN Technical Analysis vs Fundamental Analysis